Fibril fragmentation in amyloid assembly and cytotoxicity

References

• Chiti F, Dobson CM. Protein misfolding, functional amyloid and human disease. Annu Rev Biochem 2006; 75:333 - 366
   PubMed Web of Science ®Google Scholar
• Xue WF, Homans SW, Radford SE. Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc Natl Acad Sci USA 2008; 105:8926 - 8931
   PubMed Web of Science ®Google Scholar
• Tanaka M, Collins SR, Toyama BH, Weissman JS. The physical basis of how prion conformations determine strain phenotypes. Nature 2006; 442:585 - 589
   PubMed Web of Science ®Google Scholar
• Knowles TP, Fitzpatrick AW, Meehan S, Mott HR, Vendruscolo M, Dobson CM, Welland ME. Role of intermolecular forces in defining material properties of protein nanofibrils. Science 2007; 318:1900 - 1903
   PubMed Web of Science ®Google Scholar
• Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, Blake CC. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol 1997; 273:729 - 739
   PubMed Web of Science ®Google Scholar
• Meinhardt J, Sachse C, Hortschansky P, Grigorieff N, Fandrich M. Abeta(1–40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J Mol Biol 2009; 386:869 - 877
   PubMed Web of Science ®Google Scholar
• White HE, Hodgkinson JL, Jahn TR, Cohen-Krausz S, Gosal WS, Muller S, et al. Globular tetramers of beta(2)-microglobulin assemble into elaborate amyloid fibrils. J Mol Biol 2009; 389:48 - 57
   PubMed Web of Science ®Google Scholar
• Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson CM. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 1999; 96:3590 - 3594
   PubMed Web of Science ®Google Scholar
• Colvin VL. The potential environmental impact of engineered nanomaterials. Nat Biotechnol 2003; 21:1166 - 1170
   PubMed Web of Science ®Google Scholar
• Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003; 300:486 - 489
   PubMed Web of Science ®Google Scholar
• Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006; 440:352 - 357
   PubMed Web of Science ®Google Scholar
• Reixach N, Deechongkit S, Jiang X, Kelly JW, Buxbaum JN. Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci USA 2004; 101:2817 - 2822
   PubMed Web of Science ®Google Scholar
• Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 2008; 14:837 - 842
   PubMed Web of Science ®Google Scholar
• Gharibyan AL, Zamotin V, Yanamandra K, Moskaleva OS, Margulis BA, Kostanyan IA, Morozova-Roche LA. Lysozyme amyloid oligomers and fibrils induce cellular death via different apoptotic/necrotic pathways. J Mol Biol 2007; 365:1337 - 1349
   PubMed Web of Science ®Google Scholar
• Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A, et al. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease. Nature 2008; 451:720 - 724
   PubMed Web of Science ®Google Scholar
• Pieri L, Bucciantini M, Nosi D, Formigli L, Savistchenko J, Melki R, Stefani M. The yeast prion ure2p native-like assemblies are toxic to mammalian cells regardless of their aggregation state. J Biol Chem 2006; 281:15337 - 15344
   PubMed Web of Science ®Google Scholar
• Xue WF, Hellewell AL, Gosal WS, Homans SW, Hewitt EW, Radford SE. Fibril fragmentation enhances amyloid cytotoxicity. J Biol Chem 2009; 284:34272 - 34282
   PubMed Web of Science ®Google Scholar
• Xue WF, Homans SW, Radford SE. Amyloid fibril length distribution quantified by atomic force microscopy single-particle image analysis. Protein Eng Des Sel 2009; 22:489 - 496
   PubMed Web of Science ®Google Scholar
• Glabe CG. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 2006; 27:570 - 575
   PubMed Web of Science ®Google Scholar
• Morten IJ, Gosal WS, Radford SE, Hewitt EW. Investigation into the role of macrophages in the formation and degradation of beta2-microglobulin amyloid fibrils. J Biol Chem 2007; 282:29691 - 29700
   PubMed Web of Science ®Google Scholar
• Porter AE, Knowles TP, Muller K, Meehan S, McGuire E, Skepper J, et al. Imaging amyloid fibrils within cells using a Se-labelling strategy. J Mol Biol 2009; 392:868 - 871
   PubMed Web of Science ®Google Scholar
• Carulla N, Caddy GL, Hall DR, Zurdo J, Gairi M, Feliz M, et al. Molecular recycling within amyloid fibrils. Nature 2005; 436:554 - 558
   PubMed Web of Science ®Google Scholar
• Shorter J, Lindquist S. Hsp104 catalyzes formation and elimination of self-replicating sup35 prion conformers. Science 2004; 304:1793 - 1797
   PubMed Web of Science ®Google Scholar
• Platt GW, Xue WF, Homans SW, Radford SE. Probing dynamics within amyloid fibrils using a novel capping method. Angew Chem Int Ed 2009; 48:5705 - 5707
   PubMed Web of Science ®Google Scholar
• Hill TL. Length dependence of rate constants for end-to-end association and dissociation of equilibrium linear aggregates. Biophys J 1983; 44:285 - 288
   PubMed Web of Science ®Google Scholar
• Lomakin A, Benedek GB, Teplow DB. Monitoring protein assembly using quasielastic light scattering spectroscopy. Methods Enzymol 1999; 309:429 - 459
   PubMed Web of Science ®Google Scholar
• Mok YF, Howlett GJ. Sedimentation velocity analysis of amyloid oligomers and fibrils. Methods Enzymol 2006; 413:199 - 217
   PubMed Web of Science ®Google Scholar
• Ban T, Goto Y. Direct observation of amyloid growth monitored by total internal reflection fluorescence microscopy. Methods Enzymol 2006; 413:91 - 102
   PubMed Web of Science ®Google Scholar
• Baldwin AJ, Anthony-Cahill SJ, Knowles TP, Lippens G, Christodoulou J, Barker PD, Dobson CM. Measurement of amyloid fibril length distributions by inclusion of rotational motion in solution NMR diffusion measurements. Angew Chem Int Ed Engl 2008; 47:3385 - 7
   PubMed Web of Science ®Google Scholar
• Linse S, Cabaleiro-Lago C, Xue WF, Lynch I, Lindman S, Thulin E, et al. Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci USA 2007; 104:8691 - 8696
   PubMed Web of Science ®Google Scholar
• Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 2007; 104:2050 - 2055
   PubMed Web of Science ®Google Scholar
• Cabaleiro-Lago C, Quinlan-Pluck F, Lynch I, Lindman S, Minogue AM, Thulin E, et al. Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc 2008; 130:15437 - 15443
   PubMed Web of Science ®Google Scholar
• Smith JF, Knowles TP, Dobson CM, Macphee CE, Welland ME. Characterization of the nanoscale properties of individual amyloid fibrils. Proc Natl Acad Sci USA 2006; 103:15806 - 15811
   PubMed Web of Science ®Google Scholar